Haemolysis associated with continuous venovenous renal replacement circuits

Area of Science:

• Nephrology
• Critical Care Medicine
• Biomedical Engineering

Background:

• Extracorporeal circuits, including those used in continuous venovenous haemodiafiltration (CVVHD), can induce haemolysis, leading to elevated plasma-free haemoglobin (PFHb).
• Factors such as high circuit pressures and clotting are implicated in increasing the risk of haemolysis within these circuits.
• CVVHD circuits are known to experience high pressures and potential clotting over time due to their pump-driven nature.

Purpose of the Study:

• To investigate the relationship between CVVHD circuit parameters and haemolysis.
• To determine if circuit life, maximum circuit pressure, or haemofilter clotting correlates with increased PFHb levels.
• To establish safe operating limits for CVVHD circuits regarding haemolysis.

Main Methods:

• Measurement of plasma-free haemoglobin (PFHb) levels during continuous venovenous haemodiafiltration (CVVHD) treatments.
• Analysis of circuit life, maximum circuit pressure, and haemofilter clotting as potential contributing factors to haemolysis.
• Statistical evaluation to assess the significance of these parameters on PFHb levels.

Main Results:

• No significant association was found between circuit life up to 50 hours, maximum circuit pressure, or haemofilter clotting and elevated PFHb levels.
• A minor increase in PFHb was observed in circuits that operated beyond the 50-hour mark.
• CVVHD circuits demonstrated no significant haemolysis when used for durations up to 50 hours.

Conclusions:

• Continuous venovenous haemodiafiltration (CVVHD) circuits can be safely utilized for up to 50 hours without significant haemolysis.
• The findings suggest that circuit life is a critical factor, with potential for increased haemolysis beyond 50 hours.
• These results provide valuable guidance for optimizing the duration of CVVHD therapy to minimize haemolysis risk.